ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today?

Key Takeaways ADMA Biologics (ADMA) and Takeda (TAK) are leading players in the plasma derived immunoglobulin sector. ADMA markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases. On the other hand, Takeda has a well-diversified business with a focus on gastroenterology (GI), rare diseases, plasma-derived therapies (PDT), oncology and neuroscience. Given the companies' commanding position in the plasma-derived therapies market, choosing one ...